Non-prostate cancer-specific mortality rates in a cohort of > 3,000 patients

The issue of how long a man who is newly diagnosed with localized prostate cancer is likely to live before he dies a natural death from other causes is a crucial element in the decision whether to undergo treatment (and how aggressive that treatment may need to be). … READ MORE …

Prostate cancer screening and mortality of prostate cancer patients from other causes

A newly published, retrospective analysis of mortality data from participants in the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial suggests the possibility that men diagnosed with clinical symptoms of prostate cancer are at higher risk for non-prostate cancer-related mortality than men diagnosed through a screening protocol. … READ MORE …